A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ticagrelor Impurity 165 - Request Quote

Picture of Ticagrelor Impurity 165

Ticagrelor Impurity 165

SZ CAT No:SZ-T023275
CAS No
NA
Mol.F.
C14H12F2N6O
Mol.Wt.
318.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Ticagrelor Impurity 165 is chemically N-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)-5-methoxy-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine. Ticagrelor Impurity 165 is supplied with detailed characterization data compliant with regulatory guideline. Ticagrelor Impurity 165 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ticagrelor.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Ticagrelor Impurity 165

Purchase Ticagrelor Impurity 165

Ticagrelor Impurity 165 suppliers

Ticagrelor Impurity 165 manufacturers

Ticagrelor Impurity 165 price

Order Ticagrelor Impurity 165

Enquire Ticagrelor Impurity 165

Ticagrelor Impurity 165 cost

Ticagrelor Impurity 165 Supplier

Ticagrelor Impurity 165 Distributor

Ticagrelor Impurity 165 for Method Validation

Ticagrelor Reference Standard

Ticagrelor Impurity 165 for ANDA Filing

Ticagrelor Impurity 165 for Forced Degradation Studies

Ticagrelor Impurity 165 Identification Standards

Ticagrelor Impurity 165 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,